Steven W Ing1, Tonya S Orchard1, Bo Lu1, Michael J LaMonte1, Kamil E Barbour1, Jane A Cauley1, Rebecca D Jackson1. 1. Division of Endocrinology, Diabetes, and Metabolism (S.W.I., R.D.J.), Department of Human Sciences, Human Nutrition Program (T.S.O.), and Division of Biostatistics (B.L.), The Ohio State University, Columbus, Ohio 43210; Department of Epidemiology and Environmental Health (M.J.L.), University at Buffalo-State University of New York, Buffalo, New York 14260; Division of Population Health (K.E.B.), Arthritis Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30431; and Department of Epidemiology (J.A.C.), Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261.
Abstract
CONTEXT: Chronic inflammation may increase the risk of fracture, and omega-3 polyunsaturated fatty acids (PUFAs) may reduce fracture risk via down-regulation of inflammatory cytokine gene expression and other mechanisms. OBJECTIVE: We investigated associations between baseline samples of inflammatory markers, TNFα soluble receptors 1 and 2 (TNFα-sR1 and -sR2), and incident hip fracture. These associations were then tested for effect modification by dietary PUFA intake estimated by a baseline food frequency questionnaire. DESIGN AND SETTING: A nested case-control study was conducted among participants of the Women's Health Initiative Observational Study (ages, 50-79 y). Multivariable conditional logistic regression models were constructed to account for the paired design. PARTICIPANTS: This study sampled 400 pairs of hip fracture cases and controls without incident hip fracture, matched on age, year of enrollment, and menopausal hormone use. MAIN OUTCOME MEASURES: Odds ratio of hip fracture by quartile of TNF soluble receptors. RESULTS: The odds ratio of hip fracture comparing the highest to lowest quartiles was 2.24 (95% confidence interval, 1.05-4.79; P for linear trend, .048) for TNFα-sR1 and 2.83 (95% confidence interval, 1.34-5.99; P for linear trend, .011) for TNFα-sR2, adjusted for FRAX hip fracture score, nutritional variables, and selected factors impacting inflammation; there was a gradient of risk by increasing quartile in TNFα-sR1. PUFA intake did not modify these associations. CONCLUSIONS: Women with the highest levels of TNFα-sR1 and TNFα-sR2 had a greater than 2-fold increased hip fracture risk, independent of other fracture risk factors. These associations did not differ by high vs low PUFA intake.
CONTEXT: Chronic inflammation may increase the risk of fracture, and omega-3 polyunsaturated fatty acids (PUFAs) may reduce fracture risk via down-regulation of inflammatory cytokine gene expression and other mechanisms. OBJECTIVE: We investigated associations between baseline samples of inflammatory markers, TNFα soluble receptors 1 and 2 (TNFα-sR1 and -sR2), and incident hip fracture. These associations were then tested for effect modification by dietary PUFA intake estimated by a baseline food frequency questionnaire. DESIGN AND SETTING: A nested case-control study was conducted among participants of the Women's Health Initiative Observational Study (ages, 50-79 y). Multivariable conditional logistic regression models were constructed to account for the paired design. PARTICIPANTS: This study sampled 400 pairs of hip fracture cases and controls without incident hip fracture, matched on age, year of enrollment, and menopausal hormone use. MAIN OUTCOME MEASURES: Odds ratio of hip fracture by quartile of TNF soluble receptors. RESULTS: The odds ratio of hip fracture comparing the highest to lowest quartiles was 2.24 (95% confidence interval, 1.05-4.79; P for linear trend, .048) for TNFα-sR1 and 2.83 (95% confidence interval, 1.34-5.99; P for linear trend, .011) for TNFα-sR2, adjusted for FRAX hip fracture score, nutritional variables, and selected factors impacting inflammation; there was a gradient of risk by increasing quartile in TNFα-sR1. PUFA intake did not modify these associations. CONCLUSIONS:Women with the highest levels of TNFα-sR1 and TNFα-sR2 had a greater than 2-fold increased hip fracture risk, independent of other fracture risk factors. These associations did not differ by high vs low PUFA intake.
Authors: J David Curb; Anne McTiernan; Susan R Heckbert; Charles Kooperberg; Janet Stanford; Michael Nevitt; Karen C Johnson; Lori Proulx-Burns; Lisa Pastore; Michael Criqui; Sandra Daugherty Journal: Ann Epidemiol Date: 2003-10 Impact factor: 3.797
Authors: Kamil E Barbour; Li-Yung Lui; Kristine E Ensrud; Teresa A Hillier; Erin S LeBlanc; Steven W Ing; Marc C Hochberg; Jane A Cauley Journal: J Bone Miner Res Date: 2014-09 Impact factor: 6.741
Authors: Timothy Trebble; Nigel K Arden; Mike A Stroud; Stephen A Wootton; Graham C Burdge; Elizabeth A Miles; Anne B Ballinger; Rachel L Thompson; Philip C Calder Journal: Br J Nutr Date: 2003-08 Impact factor: 3.718
Authors: Tonya Orchard; Vedat Yildiz; Susan E Steck; James R Hébert; Yunsheng Ma; Jane A Cauley; Wenjun Li; Yasmin Mossavar-Rahmani; Karen C Johnson; Maryam Sattari; Meryl LeBoff; Jean Wactawski-Wende; Rebecca D Jackson Journal: J Bone Miner Res Date: 2017-02-21 Impact factor: 6.741
Authors: Sarah E Little-Letsinger; Janet Rubin; Brian Diekman; Clinton T Rubin; Cody McGrath; Gabriel M Pagnotti; Eric L Klett; Maya Styner Journal: Semin Cell Dev Biol Date: 2021-09-04 Impact factor: 7.727
Authors: Jane A Cauley; Stephen F Smagula; Kathleen M Hovey; Jean Wactawski-Wende; Christopher A Andrews; Carolyn J Crandall; Meryl S LeBoff; Wenjun Li; Mace Coday; Maryam Sattari; Hilary A Tindle Journal: J Bone Miner Res Date: 2016-09-20 Impact factor: 6.741
Authors: Jane A Cauley; Kamil E Barbour; Stephanie L Harrison; Yona K Cloonan; Michelle E Danielson; Kristine E Ensrud; Howard A Fink; Eric S Orwoll; Robert Boudreau Journal: J Bone Miner Res Date: 2016-07-25 Impact factor: 6.741
Authors: Danijela Stojanović; Petra Bůžková; Kenneth J Mukamal; Susan R Heckbert; Bruce M Psaty; Howard A Fink; Jane A Cauley; Erin Wallace; Lesley H Curtis; Calvin Hirsch; Matthew Budoff; Dong Li; Rebekah Young; Diana Jalal; Joseph Ac Delaney Journal: J Bone Miner Res Date: 2017-11-06 Impact factor: 6.741
Authors: N Veronese; B Stubbs; A Koyanagi; J R Hébert; C Cooper; M G Caruso; G Guglielmi; J Y Reginster; R Rizzoli; S Maggi; N Shivappa Journal: Osteoporos Int Date: 2017-10-10 Impact factor: 4.507